Singapore Advanced Biologics Pte. Ltd (SABio) was founded in 2010 by two Duke-NUS professors, Prof. Mariano Garcia-Blanco and Prof. Subhash Vasudevan, who perceived unmet need in quality, on-time biologics for the research community in Singapore and the region. The vision and expertise of the founders helped SABio to efficiently attract investors. In 2011, SABio received investments from Bioveda Capital and SingHealth.

Since its foundation, SABio has established a fully operational RNA oligonucleotide synthesis facility and started building its antibody catalogue. Currently, SABio offers quality siRNAs & RNA oligos, custom siRNA library production services, ready-made antibodies, antibody production services, and synthetic peptides.